Table 1.
Demographic and clinical characteristics of the patients
| Patients | ULC therapy (n=113) | RFVE therapy (n=263) | p-value | |
|---|---|---|---|---|
| Sex (M/F) |
|
72/41 (64%/36%) |
157/106 (60%/40%) |
0.5 a |
| Age (years ± SD) |
|
65.4 ± 12.5 |
60.2 ± 14.3 |
<0.001 b |
| Ischemic/hemorrhagic stroke |
|
82/31 (73%/27%) |
188/75 (71%/29%) |
0.6 a |
| Affected hemisphere (R/L) |
|
58/55 (51%/49%) |
126/137 (48%/51%) |
0.7 a |
| Upper limb motor impairment |
Severe (F-M UE≤20) |
19 (17%) |
35 (13%) |
0.6 a |
| |
Moderate (21≤F-M UE≤40) |
29 (26%) |
72 (27%) |
0.9 a |
| |
Mild (F-M UE>40) |
65 (57%) |
156 (59%) |
0.8 a |
| Stroke to Rehabilitation Interval |
≤ 3 months |
32 (28%) |
68 (26%) |
0.7 a |
| |
3 < months < 12 |
57 (50%) |
113 (43%) |
0.2 a |
| ≥ 12 months | 24 (21%) | 82 (31%) | 0.1 a |
Values are expressed as numbers and percentages. ULC Upper Limb Conventional, RFVE Reinforced Feedback in Virtual Environment, F-M UE Fugl-Meyer Upper Extremity.
a χ2 test.
b t-test.